Mar 8, 2022 06:08PM Optinose (OPTN) PT Lowered to $8 at BMO Capital

Nov 17, 2021 09:08AM Optinose (OPTN) PT Lowered to $9 at BMO Capital

Mar 5, 2020 03:09PM Optinose (OPTN) PT Lowered to $20 at BMO Capital, Following Earnings

Nov 21, 2019 09:06AM OptiNose (OPTN) Prices 5.5M Public Offering of Common Stock at $9.75/Share

Nov 21, 2019 09:00AM Optinose Announces Pricing of Public Offering of Common Stock

Nov 20, 2019 04:00PM OptiNose (OPTN) Plans Public Offering of Common Stock

Nov 20, 2019 04:00PM Optinose Announces Proposed Public Offering of Common Stock

Aug 13, 2019 07:05AM Optinose (OPTN) PT Lowered to $24 at BMO Capital

Jun 20, 2019 08:00AM Optinose to Present at the BMO Capital Markets Prescriptions for Success Healthcare Conference

Jun 20, 2019 08:00AM Optinose to Present at the BMO Capital Markets Prescriptions for Success Healthcare Conference

Dec 5, 2018 04:30PM Optinose to Present at the BMO Capital Markets Prescriptions for Success Healthcare Conference

Dec 5, 2018 04:30PM Optinose to Present at the BMO Capital Markets Prescriptions for Success Healthcare Conference

Aug 15, 2018 06:59AM Optinose (OPTN) PT Lowered to $28 at BMO Capital; Sell-Off 'Very Overdone'

Jul 12, 2018 06:34AM OptiNose's (OPTN) Xhance Xperience Continues to Gain Momentum - BMO

Jun 20, 2018 07:03AM BMO Capital Reiterates Outperform on OptiNose (OPTN) Following Investor Lunch

Jun 11, 2018 04:25PM Optinose Announces Closing of Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Common Shares

Jun 11, 2018 04:25PM Optinose Announces Closing of Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Common Shares

Jun 7, 2018 05:59AM OptiNose (OPTN) Prices 5 Million Common Shares at $22.25 Per Share

Jun 6, 2018 08:21PM Optinose Announces Pricing of Public Offering of Common Stock

Jun 6, 2018 08:21PM Optinose Announces Pricing of Public Offering of Common Stock

Jun 4, 2018 04:57PM OptiNose (OPTN) Commences 4.5M Share Offering of Common Stock

Jun 4, 2018 04:56PM Optinose Announces Launch of Public Offering of Common Stock

Jun 4, 2018 04:56PM Optinose Announces Launch of Public Offering of Common Stock

May 15, 2018 07:19AM Optinose (OPTN) PT Raised to $30 at BMO Capital

Dec 7, 2017 04:05PM Optinose to Present at BMO Capital Markets Prescription for Success Healthcare Conference

Dec 7, 2017 04:05PM Optinose to Present at BMO Capital Markets Prescription for Success Healthcare Conference

Nov 7, 2017 04:35AM BMO Capital Starts Optinose (OPTN) at Outperform, Sees Co. As Potential Takeout Target

Oct 17, 2017 04:01PM Optinose Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock

Oct 13, 2017 11:05AM OptiNose (OPTN) IPO Opens Higher